- Home
- SB vs ZVRA Comparison
SB vs ZVRA Comparison
Compare SB & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SB
- ZVRA
- Stock Information
- Founded
- SB 2007
- ZVRA 2006
- Country
- SB Monaco
- ZVRA United States
- Employees
- SB N/A
- ZVRA N/A
- Industry
- SB Marine Transportation
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- SB Consumer Discretionary
- ZVRA Health Care
- Exchange
- SB Nasdaq
- ZVRA Nasdaq
- Market Cap
- SB 379.0M
- ZVRA 419.5M
- IPO Year
- SB 2008
- ZVRA 2015
- Fundamental
- Price
- SB $3.73
- ZVRA $7.69
- Analyst Decision
- SB Strong Buy
- ZVRA Strong Buy
- Analyst Count
- SB 1
- ZVRA 7
- Target Price
- SB $6.00
- ZVRA $21.20
- AVG Volume (30 Days)
- SB 697.1K
- ZVRA 380.4K
- Earning Date
- SB 02-18-2025
- ZVRA 03-27-2025
- Dividend Yield
- SB 5.36%
- ZVRA N/A
- EPS Growth
- SB 36.11
- ZVRA N/A
- EPS
- SB 0.83
- ZVRA N/A
- Revenue
- SB $307,633,000.00
- ZVRA $24,489,000.00
- Revenue This Year
- SB $6.30
- ZVRA N/A
- Revenue Next Year
- SB N/A
- ZVRA $330.04
- P/E Ratio
- SB $4.49
- ZVRA N/A
- Revenue Growth
- SB 8.17
- ZVRA 47.85
- 52 Week Low
- SB $3.31
- ZVRA $4.20
- 52 Week High
- SB $6.33
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- SB 56.90
- ZVRA 48.77
- Support Level
- SB $3.62
- ZVRA $7.64
- Resistance Level
- SB $3.77
- ZVRA $8.21
- Average True Range (ATR)
- SB 0.13
- ZVRA 0.29
- MACD
- SB 0.02
- ZVRA 0.03
- Stochastic Oscillator
- SB 60.61
- ZVRA 57.93
About SB Safe Bulkers Inc ($0.001 par value)
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.